Drug intelligence / Profile preview

Vamousse

Development stage
Unknown
Lead developer
Alliance Pharma
Modality
Small Molecules
Administration
Topical
01

Overview

Vamousse is a **pesticide-free, topical lice treatment** in the form of an aerosol foam or mousse, indicated for the **elimination of head lice and their eggs (nits)** in adults and children aged 2 years and older[1][2][5][7]. The **active ingredient is natrum muriaticum (sodium chloride)**, which works by **disrupting the protective lipid layer of the lice exoskeleton**, leading to dehydration and death of both adult lice and eggs, rather than utilizing neurotoxic pesticides[2][5][6][7][9][10]. The product shows efficacy against both regular and “super” lice, including pesticide-resistant strains[2][7]. Treatment involves saturating dry hair and scalp, leaving for 15 minutes, then combing to remove dead lice and nits. Effectiveness is achieved with a single application, but re-treatment is allowed if needed. Developed and marketed mainly by Alliance Pharma, Vamousse is sold as an over-the-counter OTC drug. The product is labeled as unapproved homeopathic in some jurisdictions[1]. Key inactive ingredients include isopropyl myristate, isopropyl alcohol, cocamidopropyl betaine, benzyl alcohol, ammonium benzoate, sodium lauryl sulfate, butyl lactate, vanillin, geraniol, and water[1][2][5].

Brand names
Vamousse
Other names
Vamousse Lice TreatmentVamousse Head Lice Treatment

Beyond the preview

Go deeper on Vamousse.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vamousse.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call